Advertisement
OtherDrug Discovery and Translational Medicine

Optimizing IFN alpha therapy against Myeloproliferative Neoplasms

Gurvan Hermange, Paul-Henry Cournède and Isabelle Plo
Journal of Pharmacology and Experimental Therapeutics June 30, 2023, JPET-AR-2022-001561; DOI: https://doi.org/10.1124/jpet.122.001561
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherDrug Discovery and Translational Medicine

Optimizing IFNα therapy in MPN

Gurvan Hermange, Paul-Henry Cournède and Isabelle Plo
Journal of Pharmacology and Experimental Therapeutics June 30, 2023, JPET-AR-2022-001561; DOI: https://doi.org/10.1124/jpet.122.001561
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement